Published in Rev Med Suisse on April 15, 2009
Low risk of anti-human leukocyte antigen antibody sensitization after combined kidney and islet transplantation. Transplantation (2008) 1.47
Comparison of MALDI TOF with conventional identification of clinically relevant bacteria. Swiss Med Wkly (2010) 1.18
The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptors. Arthritis Res Ther (2007) 1.13
Molecular mechanism of flucytosine resistance in Candida lusitaniae: contribution of the FCY2, FCY1, and FUR1 genes to 5-fluorouracil and fluconazole cross-resistance. Antimicrob Agents Chemother (2006) 1.11
Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabine. Exp Hematol (2007) 1.07
Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab. Transpl Int (2007) 1.04
Inactivation of the FCY2 gene encoding purine-cytosine permease promotes cross-resistance to flucytosine and fluconazole in Candida lusitaniae. Antimicrob Agents Chemother (2005) 1.02
Haplotype-based banking of human pluripotent stem cells for transplantation: potential and limitations. Stem Cells Dev (2012) 1.02
Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complications. Blood (2005) 1.00
Development of an integrative transformation system for the opportunistic pathogenic yeast Candida lusitaniae using URA3 as a selection marker. Yeast (2004) 0.99
Flucytosine-fluconazole cross-resistance in purine-cytosine permease-deficient Candida lusitaniae clinical isolates: indirect evidence of a fluconazole uptake transporter. Antimicrob Agents Chemother (2003) 0.97
Donor-specific antibody levels and three generations of crossmatches to predict antibody-mediated rejection in kidney transplantation. Transplantation (2010) 0.95
Elimination of proinflammatory cytokines in pediatric cardiac surgery: analysis of ultrafiltration method and filter type. J Thorac Cardiovasc Surg (2004) 0.95
Differentiation between atypical isolates of Candida lusitaniae and Candida pulcherrima by determination of mating type. J Clin Microbiol (2005) 0.94
Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytes. Eur J Immunol (2004) 0.93
Neural progenitors derived from human embryonic stem cells are targeted by allogeneic T and natural killer cells. J Cell Mol Med (2009) 0.93
Human bone marrow stromal cells and skin fibroblasts inhibit natural killer cell proliferation and cytotoxic activity. Cell Transplant (2010) 0.89
IL-21 promotes survival and maintains a naive phenotype in human CD4+ T lymphocytes. Int Immunol (2008) 0.88
Humoral and cellular rejection after combined liver-kidney transplantation in low immunologic risk recipients. Transpl Int (2008) 0.87
Construction of skeletal myoblast-based polyurethane scaffolds for myocardial repair. Artif Organs (2007) 0.87
Selection of unrelated bone marrow donors by serology, molecular typing and cellular assays. Transpl Immunol (2002) 0.84
PLTs of blood group A1 donors express increased surface A antigen owing to apheresis and prolonged storage. Transfusion (2003) 0.83
Pluripotent stem cells as new drugs? The example of Parkinson's disease. Int J Pharm (2009) 0.83
The transcription factor RFX protects MHC class II genes against epigenetic silencing by DNA methylation. J Immunol (2009) 0.82
Microchimerism after liver transplantation: absence of rejection without abrogation of anti-donor cytotoxic T-lymphocyte-mediated alloreactivity. Liver Transpl (2005) 0.81
Natural killer cell receptor--repertoire and functions after induction therapy by polyclonal rabbit anti-thymocyte globulin in unsensitized kidney transplant recipients. Clin Immunol (2010) 0.81
Pseudovasculitis and corticosteroid therapy. Clin Rheumatol (2005) 0.81
Monitoring of CD4+CD25highIL-7Rαhigh activated T cells in kidney transplant recipients. Clin J Am Soc Nephrol (2011) 0.80
The clinical relevance of pre-formed anti-HLA and anti-MICA antibodies after cord blood transplantation in children. PLoS One (2013) 0.80
How to cross immunogenetic hurdles to human embryonic stem cell transplantation. Semin Immunopathol (2011) 0.79
Immunogenicity of Anti-HLA Antibodies in Pancreas and Islet Transplantation. Cell Transplant (2016) 0.79
Investigation of alloreactive NK cells in mixed lymphocyte reactions using paraformaldehyde-silenced target cells. J Immunol Methods (2007) 0.79
Anti-HLA antibody repertoire after IVIg infusion in highly sensitized patients waiting for kidney transplantation. Swiss Med Wkly (2006) 0.79
Cellular and gene therapy for major histocompatibility complex class II deficiency. News Physiol Sci (2004) 0.78
Posttransplant cellular immune reactivity against donor antigen correlates with clinical islet transplantation outcome: towards a better posttransplant monitoring. Cell Transplant (2012) 0.77
Is reduced systemic heparinization justified with heparin-bonded bypass circuits in cardiac surgery?--Experience with and without aprotinin. Transfus Apher Sci (2003) 0.76
Direct genetic correction as a new method for diagnosis and molecular characterization of MHC class II deficiency. Mol Ther (2002) 0.76
Protection From Varicella Zoster in Solid Organ Transplant Recipients Carrying Killer Cell Immunoglobulin-Like Receptor B Haplotypes. Transplantation (2015) 0.75
SENIORLAB: a prospective observational study investigating laboratory parameters and their reference intervals in the elderly. Medicine (Baltimore) (2017) 0.75
Early relapse of autoimmune glomerulonephritis after kidney transplantation despite antibody induction and triple-drug-based immunosuppression. Transplantation (2010) 0.75
The intellectual contribution of laboratory medicine professionals to research papers on laboratory medicine topics published in high-impact general medicine journals. Clin Chem Lab Med (2012) 0.75
Interaction of ES cell derived neural progenitor cells with natural killer cells and cytotoxic T cells. Methods Mol Biol (2013) 0.75
Restoration of hematopoiesis in a case of myelodysplastic syndrome associated with systemic lupus erythematosus treated with rituximab. Ann Hematol (2015) 0.75
A new DR7-DQ8 haplotype resulting from a recombination between the DQA1 and DQB1 loci in a leukemic patient of Caucasoid origin. Immunogenetics (2004) 0.75
Introduction: Immunopathology and the promise of stem cell research. Semin Immunopathol (2011) 0.75
HLA and non-HLA polymorphisms in renal transplantation. Swiss Med Wkly (2012) 0.75
Third-party mesenchymal stromal cell infusion is associated with a decrease in thrombotic microangiopathy symptoms observed post-hematopoietic stem cell transplantation. Pediatr Transplant (2011) 0.75
Felty's syndrome and hypofibrinogenemia: an unusual target for anti-cyclic citrullinated peptide antibodies? Mod Rheumatol (2015) 0.75